2026-06-14T02:29:31Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/137122024-09-27T08:09:24Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19605

00925njm 22002777a 4500 dc Porcuna, Jesus author Mínguez-Martínez, Jorge author Ricote, Mercedes author 2021-09-30 Peroxisome proliferator-activated receptors (PPARs) are ligand-modulated nuclear receptors that play pivotal roles in nutrient sensing, metabolism, and lipid-related processes. Correct control of their target genes requires tight regulation of the expression of different PPAR isoforms in each tissue, and the dysregulation of PPAR-dependent transcriptional programs is linked to disorders, such as metabolic and immune diseases or cancer. Several PPAR regulators and PPAR-regulated factors are epigenetic effectors, including non-coding RNAs, epigenetic enzymes, histone modifiers, and DNA methyltransferases. In this review, we examine advances in PPARα and PPARγ-related epigenetic regulation in metabolic disorders, including obesity and diabetes, immune disorders, such as sclerosis and lupus, and a variety of cancers, providing new insights into the possible therapeutic exploitation of PPAR epigenetic modulation. Int J Mol Sci. 2021 Oct; 22(19): 10573 10.3390/ijms221910573 1422-0067 International journal of molecular sciences 34638914 http://hdl.handle.net/20.500.12105/13712 The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders